Category Archives: Uncategorized
A Panel on Women Entrepreneurs in STEM features founder Laura Hales
Founder Laura Hales was one of four female entrepreneurs featured on a panel titled “She Prevailed – The Secretes to Start-up Success in STEM from Women Entrepreneurs”. The panel was sponsored by AWIS and also featured Patrice Milos, Ailis Tweed-Kent, and Teresa Nelson, and was moderated by Joanne Kamens.
Extend Biosciences is awarded a Phase II SBIR grant from NCI
Extend Biosciences was awarded a Phase II SBIR grant from the National Cancer Institute to fund efficacy and IND-enabling studies for a long-acting ghrelin molecule for cancer cachexia.
Extend Biosciences has been awarded a third patent
Extend Biosciences’ third patent has been awarded by the USPTO. The patent, titled “Insulin Vitamin D Conjugates” issued April 11, 2017 (US 9,616,109).
Founder Laura Hales wins the WIB Lobster Pot pitch competition
In a Shark Tank-style event sponsored by Women In Bio, Extend Biosciences founder Laura Hales, Ph.D. won first prize (an All-Clad Lobster Pot!) in the pitch competition in front of >100 audience members and 4 investors. The event, held at LabCentral, featured 6 companies pitching from life sciences and healthcare, and was moderated by Marian Nakada of JJDC.
Extend Biosciences is awarded a Phase I grant from NIAID
Extend Biosciences was awarded a Phase I SBIR grant from the National Institute of Allergy and Infectious Disease to work on a program for acute radiation syndrome.
Extend Biosciences says goodbye to LabCentral
Extend Biosciences has completed their 3-year maximum stay at LabCentral and said goodbye to fellow residents and staff at a happy hour in the playroom with Advirna. On February 1, Extend Bio will move to a shared laboratory facility in Newton.
Extend Biosciences’ Founder Laura Hales Speaks on a Panel on Women in STEM at a Regional SBIR Conference
Laura Hales, Cofounder of Extend Biosciences, spoke about her journey in biotech and entrepreneurship and path to successfully obtaining SBIR funding on a panel on October 5. The panel was moderated by Esther Morales, Executive Director of the National Women’s Business Council, and included Barbara Fox, PhD, Marian Nakada, PhD, and Joanne Kamens, PhD. The title of the panel was “It’s All of Our Business: Succeeding as a Woman in STEM” and was part of the preconference to the 2016 SBIR New England Regional Summit at MIT.
Extend Biosciences Featured in the NSF Innovation Zone at BIO2016
Extend Biosciences was featured in the NSF Innovation Zone at the BIO International Convention 2016 in San Francisco, CA. The company received complimentary passes to the Convention, and the technology was showcased at the company’s kiosk in the Innovation Zone with a poster and a pitch presentation by CEO Tarik Soliman.
Extend Biosciences has been Awarded a Second Patent with Broad Claims
Extend Biosciences’ second patent has been awarded by the USPTO. The patent, titled “Carriers for Improved Drug Delivery” issued March 22, 2016 (US 9,289,507). The patent includes broad claims for the use of vitamin D to improve the pharmacokinetic properties of therapeutic entities.
CEO Tarik Soliman Speaks at the Peptide Showcase East Conference
Extend Biosciences’ CEO Tarik Soliman gave a talk at the Boulder Peptide Symposium’s Peptide Showcase East conference held at the Microsoft NERD Center in Cambridge, MA. The talk was titled “Harnessing the biology of Vitamin D to enable sustained delivery of peptides and proteins.”